Posted Friday 16 June 2017
Adding to the existing evidence supporting the anti-tumorigenic properties of fucoidan, a new colorectal cancer clinical study has found that orally-ingested fucoidan significantly improved patients’ disease control rate by 24%.
Posted Monday 29 May 2017
Marinova’s fucoidan extracts have attained GRAS (Generally Recognised As Safe) status after being evaluated by an independent panel of qualified experts.
Posted Thursday 18 May 2017
Adding to existing global organic certifications, Maritech® fucoidan extracts are now non-GMO accredited, a further testament to the pure, naturally sourced Maritech® products.
Posted Monday 24 April 2017
The remarkable story of Maritech® Bright has been captured in a new video produced by boutique Australian company, Unichi Wellness, that discusses the science behind this unique skincare ingredient.
Posted Friday 31 March 2017
A new preclinical assessment has demonstrated that Maritech® fucoidan does not compromise the activity of chemotherapy drugs and is safe to use in a range of cancers.
Posted Tuesday 22 November 2016
The latest research on Maritech® fucoidan and colon cancer was presented earlier this year month at The Society of Integrative Oncology 13th International Conference in the USA.
Posted Wednesday 19 October 2016
It is spring here in Tasmania and the perfect time of year to harvest our wild Undaria pinnatifida seaweed. This seaweed, native to Japan, was first identified in Tasmania in 1988 and now grows in pockets of the island’s pristine east coast.
Posted Monday 11 July 2016
The triennial 22nd International Seaweed Symposium was held this year in Copenhagen, Denmark from the 19th to 24th June and attended by Marinova CEO, Mr Paul Garrott, and Operations Manager, Dr Damien Stringer.
Posted Friday 13 May 2016
Vitafoods Europe is a global nutraceutical event that was held this year in Geneva, Switzerland, from the 10th – 12th May. Marinova’s Business Development Manager, Mr Kevin Krail, had the pleasure of presenting Marinova’s latest research on fucoidan and cancer at the event, displayed on one of forty scientific posters that were showcased.
Posted Monday 4 April 2016
Marinova has undertaken extensive clinical and in vitro research on its two specialty cosmetic ingredients, Maritech® Bright and Maritech® Reverse, confirming an impressive range of beneficial properties. Many of these research findings feature in the latest editions of Personal Care Magazine (Asia Pacific, March 2016 and Europe, April 2016).
